Sort   by:  
 Page size 
UnknownEffect of KRAS codon 12 or 13 mutations on survival with trifluridine/tipiracil in pretreated metastatic colorectal cancer: a meta-analysis.
Not available
S-EPMC9271514 | biostudies-literature
UnknownTrifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: an exploratory subgroup analysis from the TAGS study.
Not available
S-EPMC8253956 | biostudies-literature
UnknownTrifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: a dose-expansion, phase I study.
Not available
S-EPMC8453191 | biostudies-literature
UnknownFirst-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study.
Not available
S-EPMC9130487 | biostudies-literature
UnknownLiver gene expression and its rewiring in hepatic steatosis are controlled by PI3Kα-dependent hepatocyte signaling.
Not available
S-EPMC12021288 | biostudies-literature
Sort   by:  
 Page size